Segmed
3790 El Camino Real #810, Palo Alto, CA, 94306, United States
Overview
Segmed provides real-world medical imaging data to life-sciences, health care and technology firms via a proprietary platform that acquires, de-identifies, standardizes, and delivers imaging studies. The company supports biopharmaceutical R&D, AI/ML development and real-world imaging data (RWiD) use cases. Segmed partners with health-care locations and imaging clinics across five continents to source the studies researchers and developers need. Led by CEO Martin Willemink, the company intends to use the Series A proceeds to further expand its medical imaging solutions for AI development and real-world evidence. Financially, Segmed raised $10.4M in a Series A and previously received financing from Flashpoint Growth Debt Fund in 2023. The company is headquartered in Palo Alto, California. Segmed offers a cloud-based real-world imaging platform, Segmed Insight, that enables medical researchers and AI developers to search, view studies and reports matching their criteria, and construct custom datasets. After placing an order users receive data in hand within days. The company has signed partnerships with healthcare systems, hospitals and imaging clinics across 1,000 locations on five continents. Led by CEO Martin Willemink, Segmed is based in Palo Alto, California. It raised $5.2M in a Seed+ round and has now raised more than $10M to date. The company intends to use the funds to accelerate growth, expand operations and broaden its business reach. Segmed is a secure, cloud-based platform that curates medical data by anonymizing, standardizing and labeling it to accelerate innovation in healthcare. Led by co-founder and CEO Cailin Hardell, the company partners with diverse healthcare providers around the world to source data. It standardizes and indexes medical data via a sequence of proprietary algorithms and enables customers to build customized datasets. Segmed positions itself as a shop for rapid, low-cost data aggregation and standardization for medical AI development. The company maintains strict HIPAA compliance and only uses and shares data that is fully anonymized. Financially, Segmed closed a $2M seed funding round in March 2020 to support its platform.
- Total raised
- $18M
- Funding rounds
- 3
- Latest round
- Series A
- Latest activity
- Sep 2024
Industries
- Artificial Intelligence (AI)
- Cloud Data Services
- Health Care
- Machine Learning
- Medical
Recent funding
Series A
Sep 2024
$10M
Seed
Nov 2022
$5M
Seed
Dec 2020
$2M